PhageTech Announces Key Additions to Its Management Team.Business Editors/Health & Medical Writers BIOWIRE2K MONTREAL--(BUSINESS WIRE)--Sept. 9, 2002 PhageTech Inc., a privately held antibiotic discovery company, today announced the appointments of Jinzi Jason Wu, M.D., Ph.D., as vice-president, research and development, Christian Belisle as vice-president, finance, and Serge Lapointe, Ph.D., as director of intellectual property. "We are very pleased to welcome Jinzi, Christian, and Serge to the PhageTech management team," said Dalal Manoli, PhageTech's president and chief executive officer. "Each of these executives brings extensive biotechnology and pharmaceutical industry experience that will be invaluable as we develop our proprietary small molecule antibiotics and implement plans aimed at building a leading anti-infectives company." Dr. Jinzi Jason Wu joins PhageTech with considerable expertise in small molecule drug discovery and development. His previous experience includes research positions at Immunex, where he headed a number of key small molecule discovery programs, and at such leading pharmaceutical firms as Novartis and Aventis. He received his M.D. degree from the School of Medicine, Nanjing University Nanjing University (Chinese: 南京大学; Pinyin: Nánjīng Dàxué; colloquially 南大) is a national comprehensive university located in Nanjing, an ancient capital of and his Ph.D. degree in cancer biology from the University of Arizona (body, education) University of Arizona - The University was founded in 1885 as a Land Grant institution with a three-fold mission of teaching, research and public service. , Tucson. Christian Belisle joins PhageTech with substantial finance, management and venture capital experience, most recent at Solidarity Fund QFL QFL Quebec Federation of Labour (Canada) QFL Queensland Football League QFL Quoted for Lies (internet slang) QFL Qualified Products List , where he was responsible for making that firm's business investments in biotechnology companies and served on the board of directors of several of those firms. He is a chartered accountant and member of the Order of Chartered Accountants of Quebec and holds a B. Admin. degree from the University of Sherbrooke. Dr. Serge Lapointe joins PhageTech from Montreal's intellectual property and business law firm Robic/Leger Robic Richard. As a registered patent agent for both the U.S. and Canada, Dr. Lapointe has solid experience in drafting, filing and prosecuting patent applications relating to biochemistry, cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller and genetics, and also in other aspects of patent-related matters such as patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. and validity. He received his Ph.D. from Universite Laval, Quebec. He is a member of the Intellectual Property Institute of Canada (IPIC IPIC Intellectual Property Institute of Canada IPIC Indianapolis Private Industry Council IPIC International Petroleum Investment Co (Abu Dhabi) IPIC Inventory Price Index Computation IPIC Information Processing Interagency Conference ) and of Ordre des Chimistes du Quebec. About PhageTech PhageTech, founded in 1997, is focused on the discovery and development of new classes of antibiotic drugs based on its world-leading efforts in phage phage: see bacteriophage. phage - A program that modifies other programs or databases in unauthorised ways; especially one that propagates a virus or Trojan horse. See also worm, mockingbird. The analogy, of course, is with phage viruses in biology. genomics. By unraveling the genetic code of phages, or bacterial viruses, PhageTech identifies antimicrobial proteins used by the phages to kill or stop the replication of bacteria, as well as the specific bacterial targets with which those proteins interact. The company then screens these bacterial targets to identify novel small molecule drugs that mimic the phage proteins' bactericidal bactericidal /bac·te·ri·ci·dal/ (bak-ter?i-si´d'l) destructive to bacteria. Bactericidal An agent that destroys bacteria (e.g. effects. PhageTech is headquartered in Montreal, Quebec. For more information on PhageTech, please contact Ms. Dalal Manoli, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. at 514/332-1008 or visit the company's web site at www.phagetech.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion